Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. From Wikipedia
The self-administered drug, projected to match Alnylam's Amvuttra's annual price of $463,500, is also being tested for cardiomyopathy.
